Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Eriksson

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
European Heart Journal|February 8, 2005
Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23 796 consecutive autopsiesMats Ogren, David Bergqvist, Henry Eriksson, et al.
Thrombosis and Haemostasis|November 5, 2005
Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatranHenry Eriksson, Torbjörn Lundström, Karin Wåhlander, et al.
Thrombosis and Haemostasis|November 8, 2005
Ximelagatran for the secondary prevention of venous thromboembolism: a complementary follow-up analysis of the THRIVE III studySam Schulman, Torbjörn Lundström, Karin Wålander, et al.
World Journal of Gastroenterology|April 13, 2006
Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsiesMats Ogren, David Bergqvist, Martin Björck, et al.
BMC Public Health|April 25, 2006
The prognosis for individuals on disability retirement. An 18-year mortality follow-up study of 6887 men and women sampled from the general populationThorne Wallman, Hans Wedel, Saga Johansson, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|October 14, 2003
Insulin resistance and other risk factors for coronary heart disease in elderly men. The Study of Men Born in 1913 and 1923Lennart Welin, Lars E Bresäter, Henry Eriksson, et al.
International Journal of Cancer|November 18, 2003
Lead time associated with screening for prostate cancerMagnus Törnblom, Henry Eriksson, Stefan Franzén, et al.
Clinical Pharmacology and Therapeutics|May 21, 2005
Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosisMarie Cullberg, Ulf G Eriksson, Karin Wåhlander, et al.
BMC Public Health|April 17, 2009
Sick-leave track record and other potential predictors of a disability pension. A population based study of 8,218 men and women followed for 16 yearsThorne Wallman, Hans Wedel, Edward Palmer, et al.
Open Heart|April 21, 2015
Genetic variation at the human connexin 43 locus but not at the connexin 40 locus is associated with left bundle branch blockPer Ladenvall, Björn Andersson, Mikael Dellborg, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
European Heart Journal|February 8, 2005
Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population-based study of 23 796 consecutive autopsiesMats Ogren, David Bergqvist, Henry Eriksson, et al.
Thrombosis and Haemostasis|November 5, 2005
Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatranHenry Eriksson, Torbjörn Lundström, Karin Wåhlander, et al.
Thrombosis and Haemostasis|November 8, 2005
Ximelagatran for the secondary prevention of venous thromboembolism: a complementary follow-up analysis of the THRIVE III studySam Schulman, Torbjörn Lundström, Karin Wålander, et al.
World Journal of Gastroenterology|April 13, 2006
Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsiesMats Ogren, David Bergqvist, Martin Björck, et al.
BMC Public Health|April 25, 2006
The prognosis for individuals on disability retirement. An 18-year mortality follow-up study of 6887 men and women sampled from the general populationThorne Wallman, Hans Wedel, Saga Johansson, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|October 14, 2003
Insulin resistance and other risk factors for coronary heart disease in elderly men. The Study of Men Born in 1913 and 1923Lennart Welin, Lars E Bresäter, Henry Eriksson, et al.
International Journal of Cancer|November 18, 2003
Lead time associated with screening for prostate cancerMagnus Törnblom, Henry Eriksson, Stefan Franzén, et al.
Clinical Pharmacology and Therapeutics|May 21, 2005
Pharmacokinetics of ximelagatran and relationship to clinical response in acute deep vein thrombosisMarie Cullberg, Ulf G Eriksson, Karin Wåhlander, et al.
BMC Public Health|April 17, 2009
Sick-leave track record and other potential predictors of a disability pension. A population based study of 8,218 men and women followed for 16 yearsThorne Wallman, Hans Wedel, Edward Palmer, et al.
Open Heart|April 21, 2015
Genetic variation at the human connexin 43 locus but not at the connexin 40 locus is associated with left bundle branch blockPer Ladenvall, Björn Andersson, Mikael Dellborg, et al.
Pageof 4